Coronary Disease Global Clinical Trials Review, H1, 2013

By Author: Bharat Book Bureau
Total Articles: 1486
Comment this article

Summary

“Coronary Disease Global Clinical Trials Review, H1, 2013" provides data on the Coronary Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Coronary Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. http://www.bharatbook.com/healthcare-market-research-reports/coronary-disease-global-clinical-trials-review-h1-2013.html

Scope

- Data on the number of clinical trials conducted in North America, ...
... South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Coronary Disease 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Coronary Disease 24
Subjects Recruited Over a Period of Time 29
Prominent Sponsors 30
Top Companies Participating in Coronary Disease Therapeutics Clinical Trials 32
Prominent Drug Comparison 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
AstraZeneca PLC 35
Clinical Trial Overview of AstraZeneca PLC 35
Merck & Co., Inc. 37
Clinical Trial Overview of Merck & Co., Inc. 37
Abbott Laboratories 39
Clinical Trial Overview of Abbott Laboratories 39
Cordis Corporation 40
Clinical Trial Overview of Cordis Corporation 40
Hoffmann-La Roche Inc. 41
Clinical Trial Overview of Hoffmann-La Roche Inc. 41
GlaxoSmithKline plc 42
Clinical Trial Overview of GlaxoSmithKline plc 42
Novartis AG 43
Clinical Trial Overview of Novartis AG 43
Pfizer Inc. 44
Clinical Trial Overview of Pfizer Inc. 44
TCA Cellular Therapy, LLC 45
Clinical Trial Overview of TCA Cellular Therapy, LLC 45
Schering-Plough Limited 46
Clinical Trial Overview of Schering-Plough Limited 46
AbbVie Inc. 47
Clinical Trial Overview of AbbVie Inc. 47
F. Hoffmann-La Roche Ltd. 48
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 48
Sanofi 49
Clinical Trial Overview of Sanofi 49
Acusphere, Inc. 50
Clinical Trial Overview of Acusphere, Inc. 50
The Medicines Company 51
Clinical Trial Overview of The Medicines Company 51
Scios Inc. 52
Clinical Trial Overview of Scios Inc. 52
Sarepta Therapeutics, Inc. 53
Clinical Trial Overview of Sarepta Therapeutics, Inc. 53
CardioDx, Inc. 54
Clinical Trial Overview of CardioDx, Inc. 54
Resverlogix Corp. 55
Clinical Trial Overview of Resverlogix Corp. 55
Minvasys 56
Clinical Trial Overview of Minvasys 56
Clinical Trial Overview of Top Universities / Institutes / Hospitals 57
Deutsches Herzzentrum Munchen 57
Clinical Trial Overview of Deutsches Herzzentrum Munchen 57
Brigham and Women's Hospital 59
Clinical Trial Overview of Brigham and Women's Hospital 59
Medical University of Vienna 60
Clinical Trial Overview of Medical University of Vienna 60
The University of Edinburgh 61
Clinical Trial Overview of The University of Edinburgh 61
Seoul National University Hospital 62
Clinical Trial Overview of Seoul National University Hospital 62
University of Nebraska 63
Clinical Trial Overview of University of Nebraska 63
Assistance Publique - Hopitaux de Paris 64
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 64
University of California, San Francisco 65
Clinical Trial Overview of University of California, San Francisco 65
University of Ottawa Heart Institute 66
Clinical Trial Overview of University of Ottawa Heart Institute 66
William Beaumont Hospitals 67
Clinical Trial Overview of William Beaumont Hospitals 67
China Academy of Chinese Medical Sciences 68
Clinical Trial Overview of China Academy of Chinese Medical Sciences 68
University of Pittsburgh 69

For more information kindly visit :
Coronary Disease Global Clinical Trials Review, H1, 2013
Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: https://twitter.com/researchbook
Follow us on linkedin : http://www.linkedin.com/company/bharat-book-bureau
Our Blog : http://blog.bharatbook.com/